NYSE:CRY - CryoLife Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$26.75 +0.30 (+1.13 %)
(As of 05/24/2018 02:26 AM ET)
Previous Close$26.45
Today's Range$26.35 - $26.90
52-Week Range$16.80 - $27.25
Volume86,300 shs
Average Volume117,740 shs
Market Capitalization$978.08 million
P/E Ratio66.88
Dividend YieldN/A
Beta0.73

About CryoLife (NYSE:CRY)

CryoLife logoCryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves for aortic and mitral indications; cardiac preservation services; PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries. The company also provides cardiac laser therapy products, which include laser consoles, related service and maintenance, and single-use, as well as fiber-optic hand-pieces for the treatment of coronary artery disease in patients with severe angina. In addition, it distributes E-vita OPEN PLUS, a hybrid stent graft systems for the surgical and endovascular treatment; E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; E-vita THORACIC 3G is a stent graft system for the endovascular treatment of thoracic aortic aneurysms; and E-tegra, an abdominal aortic aneurysms stent graft system for the endovascular treatment. Further, the company offers vascular preservation services; and synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures. The company serves physicians, hospitals, and other healthcare industries, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

Receive CRY News and Ratings via Email

Sign-up to receive the latest news and ratings for CRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:CRY
CUSIP22890310
Phone770-419-3355

Debt

Debt-to-Equity Ratio0.77
Current Ratio5.07
Quick Ratio3.72

Price-To-Earnings

Trailing P/E Ratio66.88
Forward P/E Ratio89.17
P/E GrowthN/A

Sales & Book Value

Annual Sales$189.70 million
Price / Sales5.17
Cash Flow$0.7058 per share
Price / Cash37.90
Book Value$7.67 per share
Price / Book3.49

Profitability

EPS (Most Recent Fiscal Year)$0.40
Net Income$3.70 million
Net Margins-1.15%
Return on Equity4.55%
Return on Assets2.50%

Miscellaneous

Employees1,000
Outstanding Shares36,630,000

CryoLife (NYSE:CRY) Frequently Asked Questions

What is CryoLife's stock symbol?

CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How were CryoLife's earnings last quarter?

CryoLife (NYSE:CRY) issued its quarterly earnings data on Wednesday, May, 2nd. The medical equipment provider reported $0.02 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.02. The medical equipment provider had revenue of $61.95 million for the quarter, compared to the consensus estimate of $60.30 million. CryoLife had a negative net margin of 1.15% and a positive return on equity of 4.55%. The firm's revenue for the quarter was up 37.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.09 earnings per share. View CryoLife's Earnings History.

When is CryoLife's next earnings date?

CryoLife is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for CryoLife.

What guidance has CryoLife issued on next quarter's earnings?

CryoLife updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $0.29-0.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.31. The company issued revenue guidance of $250-256 million, compared to the consensus revenue estimate of $252.86 million.

What price target have analysts set for CRY?

3 equities research analysts have issued 12 month price targets for CryoLife's shares. Their predictions range from $23.50 to $28.00. On average, they expect CryoLife's share price to reach $25.8333 in the next twelve months. View Analyst Ratings for CryoLife.

What are Wall Street analysts saying about CryoLife stock?

Here are some recent quotes from research analysts about CryoLife stock:
  • 1. According to Zacks Investment Research, "CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries. " (5/11/2018)
  • 2. Northland Securities analysts commented, "SER-109 stumbles do not impact the long game, in our view. To us, the attractiveness of MCRB’s C. difficile infection (CDI) programs is more about establishing proof of concept (POC) that the microbiome can be manipulated for therapeutic purposes than their revenue potential. If the IBD and/or cancer immunotherapy programs are successful, we believe far larger commercial opportunities could emerge." (3/8/2018)
  • 3. Canaccord Genuity analysts commented, "We are updating our model and now include 2019 estimates. We reiterate our BUY rating and $25 price target." (1/3/2018)

Who are some of CryoLife's key competitors?

Who are CryoLife's key executives?

CryoLife's management team includes the folowing people:
  • Mr. James Patrick MacKin, Chairman, Pres & CEO (Age 51)
  • Mr. David Ashley Lee, Exec. VP, COO & CFO (Age 53)
  • Ms. Jean F. Holloway, Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. (Age 61)
  • Mr. John E. Davis, Sr. VP of Global Sales & Marketing (Age 53)
  • Ms. Amy D. Horton, VP & Chief Accounting Officer (Age 48)

Has CryoLife been receiving favorable news coverage?

Headlines about CRY stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CryoLife earned a daily sentiment score of 0.21 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 45.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are CryoLife's major shareholders?

CryoLife's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.17%), Dimensional Fund Advisors LP (5.48%), Northern Trust Corp (3.20%), Elk Creek Partners LLC (1.72%), Thomson Horstmann & Bryant Inc. (0.94%) and Principal Financial Group Inc. (0.72%). Company insiders that own CryoLife stock include Amy Horton, C Elkins Ronald, David Ashley Lee, David C Gale, James Benson, James P Mackin, John E Davis, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for CryoLife.

Which major investors are selling CryoLife stock?

CRY stock was sold by a variety of institutional investors in the last quarter, including Penn Capital Management Co. Inc., Elk Creek Partners LLC, JPMorgan Chase & Co., Citadel Advisors LLC, American International Group Inc., Dimensional Fund Advisors LP, Royal Bank of Canada and NBW Capital LLC. Company insiders that have sold CryoLife company stock in the last year include Amy Horton, C Elkins Ronald, David Ashley Lee, David C Gale, James Benson, James P Mackin, John E Davis and Ronald D Mccall. View Insider Buying and Selling for CryoLife.

Which major investors are buying CryoLife stock?

CRY stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Millrace Asset Group Inc., Monarch Partners Asset Management LLC, California Public Employees Retirement System, Northern Trust Corp, Wells Fargo & Company MN, Victory Capital Management Inc. and Thomson Horstmann & Bryant Inc.. View Insider Buying and Selling for CryoLife.

How do I buy shares of CryoLife?

Shares of CRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CryoLife's stock price today?

One share of CRY stock can currently be purchased for approximately $26.75.

How big of a company is CryoLife?

CryoLife has a market capitalization of $978.08 million and generates $189.70 million in revenue each year. The medical equipment provider earns $3.70 million in net income (profit) each year or $0.40 on an earnings per share basis. CryoLife employs 1,000 workers across the globe.

How can I contact CryoLife?

CryoLife's mailing address is 1655 Roberts Boulevard N.W, Kennesaw GA, 30144. The medical equipment provider can be reached via phone at 770-419-3355.


MarketBeat Community Rating for CryoLife (CRY)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  206 (Vote Outperform)
Underperform Votes:  142 (Vote Underperform)
Total Votes:  348
MarketBeat's community ratings are surveys of what our community members think about CryoLife and other stocks. Vote "Outperform" if you believe CRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CryoLife (NYSE:CRY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for CryoLife in the last 12 months. Their average twelve-month price target is $25.8333, suggesting that the stock has a possible downside of 3.43%. The high price target for CRY is $28.00 and the low price target for CRY is $23.50. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.8333$25.8333$24.8333$23.6250
Price Target Upside: 3.43% downside16.89% upside30.02% upside26.68% upside

CryoLife (NYSE:CRY) Consensus Price Target History

Price Target History for CryoLife (NYSE:CRY)

CryoLife (NYSE:CRY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/9/2018Canaccord GenuityReiterated RatingBuy$25.00 ➝ $28.00HighView Rating Details
3/8/2018Northland SecuritiesReiterated RatingBuy$23.50HighView Rating Details
10/11/2017Lake Street CapitalBoost Price TargetBuy$26.00N/AView Rating Details
2/17/2017Ladenburg ThalmannUpgradeNeutral ➝ Buy$20.00N/AView Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

CryoLife (NYSE:CRY) Earnings History and Estimates Chart

Earnings by Quarter for CryoLife (NYSE:CRY)

CryoLife (NYSE:CRY) Earnings Estimates

2018 EPS Consensus Estimate: $0.29
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.01$0.01$0.01
Q2 20181$0.07$0.07$0.07
Q3 20181$0.07$0.07$0.07
Q4 20181$0.14$0.14$0.14
Q1 20191$0.08$0.08$0.08

CryoLife (NYSE CRY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/23/2018$0.08N/AView Earnings Details
5/2/2018Q1 2018$0.02$0.02$60.30 million$61.95 millionViewN/AView Earnings Details
3/7/2018Q4 2017$0.11$0.11$48.40 million$52.80 millionViewListenView Earnings Details
10/30/2017Q3 2017$0.08$0.08$44.60 million$44.00 millionViewN/AView Earnings Details
7/24/2017Q2 2017$0.10$0.12$47.02 million$47.80 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.04$0.09$44.64 million$45.10 millionViewN/AView Earnings Details
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.0170$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/15/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
11/4/2010Q3 2010$0.09$0.09ViewN/AView Earnings Details
7/29/2010Q2 2010$0.09$0.10ViewN/AView Earnings Details
4/28/2010Q1 2010$0.08$0.07ViewN/AView Earnings Details
2/18/2010Q4 2009$0.08$0.09ViewN/AView Earnings Details
10/29/2009Q3 2009$0.07$0.07ViewN/AView Earnings Details
7/30/2009Q2 2009$0.08$0.09ViewN/AView Earnings Details
4/30/2009Q1 2009$0.06$0.07ViewN/AView Earnings Details
2/19/2009Q4 2008$0.10$0.10ViewN/AView Earnings Details
10/30/2008Q3 2008$0.08$0.12ViewN/AView Earnings Details
7/31/2008Q2 2008$0.10$0.12ViewN/AView Earnings Details
4/30/2008Q1 2008$0.09$0.10ViewN/AView Earnings Details
2/21/2008Q4 2007$0.08$0.10ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

CryoLife (NYSE:CRY) Dividend Information

CryoLife pays an annual dividend of $0.00 per share, with a dividend yield of 0.00%. CRY's most recent quarterly dividend payment was Friday, December 18. CryoLife pays out 0.00% of its earnings out as a dividend.
Most Recent Dividend:12/18/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio(s):0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
0.00% (Based on Cash Flow)
Dividend Payments by Quarter for CryoLife (NYSE:CRY)

CryoLife (NYSE:CRY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/22/2015quarterly$0.031.22%12/9/201512/11/201512/18/2015
7/22/2015quarterly$0.031.07%9/9/20159/11/20159/18/2015
5/21/2015quarterly$0.031.08%6/10/20156/12/20156/19/2015
2/13/2015quarterly$0.031.12%3/11/20153/13/20153/20/2015
10/23/2014quarterly$0.031.14%12/10/201412/12/201412/19/2014
7/30/2014quarterly$0.031.22%9/10/20149/12/20149/19/2014
5/22/2014quarterly$0.031.38%6/11/20146/13/20146/20/2014
2/19/2014quarterly$0.02751.17%3/12/20143/14/20143/21/2014
11/21/2013quarterly$0.02751.05%12/11/201312/13/201312/20/2013
8/21/2013quarterly$0.02751.72%9/11/20139/13/20139/20/2013
5/28/2013quarterly$0.02751.75%6/12/20136/14/20136/21/2013
2/13/2013quarterly$0.02501.61%3/12/20133/14/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

CryoLife (NYSE CRY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.97%
Institutional Ownership Percentage: 67.47%
Insider Trading History for CryoLife (NYSE:CRY)
Institutional Ownership by Quarter for CryoLife (NYSE:CRY)

CryoLife (NYSE CRY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018John E DavisVPSell4,373$27.00$118,071.0055,811View SEC Filing  
5/14/2018C Elkins RonaldDirectorSell10,000$24.75$247,500.0078,997View SEC Filing  
5/10/2018C Elkins RonaldDirectorSell6,852$25.38$173,903.76144,271View SEC Filing  
5/9/2018Amy HortonCAOSell4,000$25.94$103,760.0098,959View SEC Filing  
5/9/2018David Ashley LeeCFOSell10,000$25.70$257,000.00290,079View SEC Filing  
5/8/2018Ronald D MccallDirectorSell260$25.95$6,747.00142,011View SEC Filing  
4/17/2018John E DavisVPSell3,333$23.00$76,659.0054,771View SEC Filing  
3/8/2018C Elkins RonaldDirectorSell2,000$22.00$44,000.0097,849View SEC Filing  
12/15/2017C Elkins RonaldDirectorSell1,000$20.00$20,000.0099,849View SEC Filing  
11/16/2017David C GaleVPSell20,000$19.63$392,600.00View SEC Filing  
11/8/2017Amy HortonCAOSell4,000$19.00$76,000.0098,705View SEC Filing  
11/8/2017David Ashley LeeCFOSell33,190$19.00$630,610.00324,339View SEC Filing  
11/6/2017C Elkins RonaldDirectorSell1,000$19.03$19,030.00100,849View SEC Filing  
10/2/2017James BensonDirectorSell2,000$22.80$45,600.00View SEC Filing  
9/6/2017James P MackinCEOSell125,000$22.01$2,751,250.00398,399View SEC Filing  
9/5/2017C Elkins RonaldDirectorSell1,000$22.00$22,000.00101,849View SEC Filing  
9/5/2017James P MackinCEOSell43,050$22.09$950,974.50398,399View SEC Filing  
6/27/2017Amy HortonVPSell9,577$20.00$191,540.00112,282View SEC Filing  
2/22/2017Scott B CappsVPSell11,083$16.40$181,761.20128,477View SEC Filing  
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00103,586View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00156,248View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.0065,352View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.0096,852View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.0097,852View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00363,933View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.0091,873View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00243,284View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00244,269View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00243,969View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.3570,352View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.3576,993View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72101,528View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.001,385,810View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.1034,564View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.0079,099View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.0079,099View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.001,358,120View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.0036,608View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.0057,574View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CryoLife (NYSE CRY) News Headlines

Source:
DateHeadline
John E. Davis Sells 4,373 Shares of CryoLife (CRY) StockJohn E. Davis Sells 4,373 Shares of CryoLife (CRY) Stock
www.americanbankingnews.com - May 18 at 8:19 PM
C Elkins Ronald Sells 10,000 Shares of CryoLife (CRY) StockC Elkins Ronald Sells 10,000 Shares of CryoLife (CRY) Stock
www.americanbankingnews.com - May 15 at 7:52 PM
CryoLife (CRY) Stock Gains 9.5% on Impressive Q1 EarningsCryoLife (CRY) Stock Gains 9.5% on Impressive Q1 Earnings
www.zacks.com - May 15 at 9:20 AM
CryoLife (CRY) Upgraded by Zacks Investment Research to BuyCryoLife (CRY) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - May 11 at 8:33 PM
Insider Selling: CryoLife (CRY) CAO Sells 4,000 Shares of StockInsider Selling: CryoLife (CRY) CAO Sells 4,000 Shares of Stock
www.americanbankingnews.com - May 11 at 8:20 PM
CryoLife (CRY) CFO Sells $257,000.00 in StockCryoLife (CRY) CFO Sells $257,000.00 in Stock
www.americanbankingnews.com - May 11 at 8:01 PM
First Analysis Weighs in on CryoLifes Q2 2018 Earnings (CRY)First Analysis Weighs in on CryoLife's Q2 2018 Earnings (CRY)
www.americanbankingnews.com - May 11 at 9:05 AM
Insider Selling: CryoLife (CRY) Director Sells 6,852 Shares of StockInsider Selling: CryoLife (CRY) Director Sells 6,852 Shares of Stock
www.americanbankingnews.com - May 10 at 7:53 PM
CryoLife (CRY) Downgraded by Zacks Investment ResearchCryoLife (CRY) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 8 at 9:42 PM
CryoLifes (CRY) CEO Pat Mackin on Q1 2018 Results - Earnings Call TranscriptCryoLife's (CRY) CEO Pat Mackin on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 9:03 AM
Edited Transcript of CRY earnings conference call or presentation 3-May-18 12:00pm GMTEdited Transcript of CRY earnings conference call or presentation 3-May-18 12:00pm GMT
finance.yahoo.com - May 4 at 8:52 AM
CryoLife (CRY) Reports In-Line Q1 EPSCryoLife (CRY) Reports In-Line Q1 EPS
www.streetinsider.com - May 3 at 8:51 AM
CryoLife: 1Q Earnings SnapshotCryoLife: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 8:51 AM
CryoLife Reports First Quarter 2018 ResultsCryoLife Reports First Quarter 2018 Results
finance.yahoo.com - May 3 at 8:51 AM
CryoLife (CRY) Upgraded at Zacks Investment ResearchCryoLife (CRY) Upgraded at Zacks Investment Research
www.americanbankingnews.com - May 2 at 11:06 PM
CryoLife (CRY) Releases FY18 Earnings GuidanceCryoLife (CRY) Releases FY18 Earnings Guidance
www.americanbankingnews.com - May 2 at 9:19 PM
CryoLife (CRY) Posts Quarterly  Earnings Results, Hits ExpectationsCryoLife (CRY) Posts Quarterly Earnings Results, Hits Expectations
www.americanbankingnews.com - May 2 at 9:18 PM
CryoLife (CRY) and Endologix (ELGX) Critical AnalysisCryoLife (CRY) and Endologix (ELGX) Critical Analysis
www.americanbankingnews.com - May 2 at 1:35 PM
Interested In CryoLife Inc (NYSE:CRY)? Here’s How It Performed RecentlyInterested In CryoLife Inc (NYSE:CRY)? Here’s How It Performed Recently
finance.yahoo.com - May 2 at 8:55 AM
CryoLife to Present at Deutsche Bank 43rd Annual Health Care ConferenceCryoLife to Present at Deutsche Bank 43rd Annual Health Care Conference
finance.yahoo.com - May 1 at 8:59 AM
CryoLife (CRY) Receives Average Rating of "Hold" from AnalystsCryoLife (CRY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 29 at 8:16 AM
Analyzing LeMaitre Vascular (LMAT) and CryoLife (CRY)Analyzing LeMaitre Vascular (LMAT) and CryoLife (CRY)
www.americanbankingnews.com - April 26 at 3:14 PM
CryoLife (CRY) Scheduled to Post Quarterly Earnings on WednesdayCryoLife (CRY) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 25 at 9:02 AM
CryoLife (CRY) VP John E. Davis Sells 3,333 SharesCryoLife (CRY) VP John E. Davis Sells 3,333 Shares
www.americanbankingnews.com - April 18 at 7:49 PM
CryoLife Announces Release Date and Teleconference Call Details for 2018 First Quarter Financial ResultsCryoLife Announces Release Date and Teleconference Call Details for 2018 First Quarter Financial Results
finance.yahoo.com - April 17 at 5:20 PM
CryoLife (CRY) Set to Announce Earnings on TuesdayCryoLife (CRY) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - April 17 at 4:11 AM
CryoLife (CRY) Rating Lowered to Hold at BidaskClubCryoLife (CRY) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 16 at 8:40 PM
Head to Head Analysis: CryoLife (CRY) and Orthofix International (OFIX)Head to Head Analysis: CryoLife (CRY) and Orthofix International (OFIX)
www.americanbankingnews.com - April 15 at 11:15 AM
CryoLife (CRY) Downgraded to "Sell" at BidaskClubCryoLife (CRY) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - April 14 at 6:22 PM
Cryolife Inc (CRY) Receives Consensus Rating of "Hold" from AnalystsCryolife Inc (CRY) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 4 at 9:58 AM
Cryolife (CRY) Cut to C+ at TheStreetCryolife (CRY) Cut to C+ at TheStreet
www.americanbankingnews.com - April 2 at 3:15 PM
Cryolife (CRY) Receives "Buy" Rating from Canaccord GenuityCryolife (CRY) Receives "Buy" Rating from Canaccord Genuity
www.americanbankingnews.com - March 31 at 6:52 AM
CryoLife to Present at 17th Annual Needham Healthcare ConferenceCryoLife to Present at 17th Annual Needham Healthcare Conference
finance.yahoo.com - March 20 at 9:08 AM
Cryolife (CRY) Cut to Sell at ValuEngineCryolife (CRY) Cut to Sell at ValuEngine
www.americanbankingnews.com - March 19 at 10:40 PM
Edited Transcript of CRY earnings conference call or presentation 8-Mar-18 1:00pm GMTEdited Transcript of CRY earnings conference call or presentation 8-Mar-18 1:00pm GMT
finance.yahoo.com - March 18 at 8:53 AM
Form 4 CRYOLIFE INC For: Mar 12 Filed by: Holloway Jean FForm 4 CRYOLIFE INC For: Mar 12 Filed by: Holloway Jean F
www.streetinsider.com - March 16 at 9:06 AM
Global Wound Closure Market Opportunities 2018: Smith and Nephew plc, Derma Sciences , CryoLife , Medtronic plcGlobal Wound Closure Market Opportunities 2018: Smith and Nephew plc, Derma Sciences , CryoLife , Medtronic plc
www.marketwatch.com - March 16 at 9:06 AM
Cryolife (CRY) Cut to Sell at Zacks Investment ResearchCryolife (CRY) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - March 13 at 8:00 PM
Cryolife Inc (CRY) to Post Q2 2018 Earnings of $0.01 Per Share, First Analysis ForecastsCryolife Inc (CRY) to Post Q2 2018 Earnings of $0.01 Per Share, First Analysis Forecasts
www.americanbankingnews.com - March 12 at 3:24 AM
Cryolife Inc (CRY) Receives Average Rating of "Hold" from AnalystsCryolife Inc (CRY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - March 10 at 7:36 AM
Insider Selling: Cryolife Inc (CRY) Director Sells 2,000 Shares of StockInsider Selling: Cryolife Inc (CRY) Director Sells 2,000 Shares of Stock
www.americanbankingnews.com - March 9 at 7:16 PM
Cryolife (CRY) Stock Rating Reaffirmed by Canaccord GenuityCryolife (CRY) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - March 9 at 8:11 AM
Cryolife (CRY) Rating Reiterated by Northland SecuritiesCryolife (CRY) Rating Reiterated by Northland Securities
www.americanbankingnews.com - March 8 at 8:08 PM
CryoLife (CRY) Beats Earnings and Revenue Estimates in Q4CryoLife (CRY) Beats Earnings and Revenue Estimates in Q4
finance.yahoo.com - March 8 at 5:56 PM
CryoLife Reports Fourth Quarter and Full Year 2017 ResultsCryoLife Reports Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - March 8 at 9:07 AM
CryoLife reports 4Q lossCryoLife reports 4Q loss
finance.yahoo.com - March 8 at 9:07 AM
CryoLife EPS in-line, beats on revenueCryoLife EPS in-line, beats on revenue
seekingalpha.com - March 7 at 11:10 PM
Cryolife (CRY) Issues FY18 Earnings GuidanceCryolife (CRY) Issues FY18 Earnings Guidance
www.americanbankingnews.com - March 7 at 9:14 PM
Royce & Associates LP Has $7.43 Million Stake in Cryolife Inc (CRY)Royce & Associates LP Has $7.43 Million Stake in Cryolife Inc (CRY)
www.americanbankingnews.com - February 28 at 9:42 AM
Cryolife (CRY) Set to Announce Earnings on WednesdayCryolife (CRY) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - February 28 at 2:52 AM

SEC Filings

CryoLife (NYSE:CRY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CryoLife (NYSE:CRY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CryoLife (NYSE CRY) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.